Freedom of Information Request: 0322 2019/20
University Hospitals Birmingham NHS Foundation Trust (UHB) completed a merger by acquisition of Heart of England NHS Foundation Trust (HEFT) on 1st April 2018. Due to historical differences in data collection/reporting across UHB and the former Heart of England NHS Foundation Trust this response has been provided by hospital site.
This is a freedom of information request for dermatitis and asthma; please answer as many of the questions as possible. If unknown or no data, please state “not known”
Queen Elizabeth Hospital Birmingham
1. How many patients were treated, in the last 3 months available for moderate or severe atopic dermatitis? 17 1a. Of these treated patients how many are paediatric? 0
2. How many patients were treated, in the last 3 months available for moderate or severe atopic dermatitis with the following drugs? 3
Acitretin
Alitretinoin
Pimecrolimus
Tacrolimus
Dupilumab [Dupixent]
Etanercept
Infliximab
Adalimumab
Ustekinumab
Please note there is no way to deduce the severity of atopic dermatitis
3. How many patients aged 18 and over, were treated in the last 3 months available for asthma? 1952
4. How many patients aged 17 and under, were treated in the last 3 months available for asthma? 19
5. How many asthma patients were treated in the last 3 months available with: 29
Omalizumab [Xolair]
Mepolizumab [Nucala]
Reslizumab [Cinqaero]
Benralizumab [Fasenra]
6. How many paediatric severe asthma patients have been treated with Xolair/omalizumab in the last 3 months available? 0
7. How many chronic spontaneous urticaria (CSU) patients have been treated with Xolair/omalizumab in the last 3 months available? 0
Heartlands, Good Hope and Solihull Hospital
1. How many patients were treated, in the last 3 months available for moderate or severe atopic dermatitis? 23 1a. Of these treated patients how many are paediatric? 8
2. How many patients were treated, in the last 3 months available for moderate or severe atopic dermatitis with the following drugs? Not Known (We do not hold this information)
Acitretin
Alitretinoin
Pimecrolimus
Tacrolimus
Dupilumab [Dupixent]
Etanercept
Infliximab
Adalimumab
Ustekinumab
3. How many patients aged 18 and over, were treated in the last 3 months available for asthma? 4924
4. How many patients aged 17 and under, were treated in the last 3 months available for asthma? 301
5. How many asthma patients were treated in the last 3 months available with: Not Known (We do not hold this information)
Omalizumab [Xolair]
Mepolizumab [Nucala]
Reslizumab [Cinqaero]
Benralizumab [Fasenra]
6. How many paediatric severe asthma patients have been treated with Xolair/omalizumab in the last 3 months available? Not Known (We do not hold this information)
7. How many chronic spontaneous urticaria (CSU) patients have been treated with Xolair/omalizumab in the last 3 months available? Not Known (We do not hold this information)
